COMMUNIQUÉS West-GlobeNewswire

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy
15/07/2026
STUDIO CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Study results from the randomized, prospective phase III ENDURANCE (E1A11) trial, designed and conducted by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN), were [...]
Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026
15/07/2026
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter [...]
Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency
15/07/2026
Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical improvement in a patient with treatment-refractory SLE Results provide first human [...]
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026
15/07/2026
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and [...]
First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer
15/07/2026
First patients dosed in OPTIMAL-e 1 Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent’s Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier prostate cancer [...]
Rakovina Therapeutics Announces $1.5 Million Private Placement
15/07/2026
VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV)( FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)- [...]
ARCPOINT ANTICIPATES DELAY IN FILING ANNUAL FINANCIAL STATEMENTS
16/07/2026
GREENVILLE, South Carolina, July 15, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the " Company " or “ ARCpoint ”) announces that it will likely miss its filing deadline of July 29, 2026 (the “ Annual Filing [...]
Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program
15/07/2026
Peer-reviewed journal's News section highlights the Company’s continued progress toward a fully implantable total artificial heart TUCSON, Ariz., July 15, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: [...]
Medicare Covers Online Therapy in New York: MMHC's Medicare-Enrolled Therapists Now Accepting New Patients Statewide at $0 to $27 Per Session
15/07/2026
Every therapist at Manhattan Mental Health Counseling is enrolled in Medicare and bills Medicare directly; no referral required, no annual session limits, exact cost confirmed before session one, and first sessions [...]
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directors
15/07/2026
AUSTIN, Texas, July 15, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today [...]
Celldex Announces Planned Transition of Chief Financial Officer
15/07/2026
HAMPTON, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that Sam Martin, Senior Vice President and Chief Financial Officer, has informed the Company of his plans to retire in 2027. Mr. [...]
PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026
15/07/2026
MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5, [...]
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
15/07/2026
CHASKA, Minn., July 15, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that [...]
Teladoc Health to Announce Second Quarter 2026 Financial Results
15/07/2026
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
15/07/2026
SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
15/07/2026
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the [...]
RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer
15/07/2026
ALISO VIEJO, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive [...]
Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026
15/07/2026
RADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026 [...]
Arcutis to Report Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
15/07/2026
WESTLAKE VILLAGE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

Pages